Search results for "HCV cirrhosis"

showing 5 items of 5 documents

GENETIC, VIROLOGICAL AND CLINICAL FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPEMENT IN PATIENTS WITH CHRONIC HBV AND HCV INFECTION

HCV cirrhosiSettore MED/12 - GastroenterologiaMERTK geneqHBsAg level serumchronic HBV infectionchronic HCV infectiongenetic factorclinical factors HBV cirrhosihepatocellular carcinomavirological factorchronic HBV infection; chronic HCV infection; hepatocellular carcinoma; genetic factors; virological factor; clinical factors HBV cirrhosis; HCV cirrhosis; MERTK gene; qHBsAg level serum
researchProduct

HCV cirrhosis at the edge of decompensation: Will ABT-450/r, ombitasvir, da- sabuvir and ribavirin solve the need for treatment?

2014

HCV cirrhosis
researchProduct

Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

2019

Background & aims: The effectiveness of direct-acting antivirals (DAAs) against hepatitis C virus (HCV) after successful treatment of early hepatocellular carcinoma (HCC) has been studied extensively. However, the benefit in terms of overall survival (OS) remains to be conclusively demonstrated. The aim of this study was to assess the impact of DAAs on OS, HCC recurrence, and hepatic decompensation. Methods: We enrolled prospectively 163 consecutive patients with HCV-related cirrhosis and at first diagnosis of early Barcelona Clinic Liver Cancer (BCLC) 0/A HCC who had achieved a complete radiologic response after curative resection or ablation, subsequently treated with DAAs. DAA-untrea…

HepatologyGastroenterologyDAA Hepatocelluar carcinoma survival HCV cirrhosis
researchProduct

COMPUTER ASSISTED IMAGE ANALYSIS OF LIVER COLLAGEN: RELATIONSHIP TO ESOPHAGEAL VARICES, LIVER DECOMPENSATION AND SVR IN PATIENTS WITH COMPENSATED HCV…

2011

SVRLIVER DECOMPENSATIONHCV CIRRHOSISESOPHAGEAL VARICES
researchProduct

Correlation between the single nucleotide polymorphism (SNP) rs4374383 in MERTK gene with the risk of development and progression of liver disease

Settore BIO/13 - Biologia Applicatachronic hepatitis B and C NASH NAFLD MERTK GENE HEPATOCELLULAR CARCINOMA GENETIC FACTORS HSCs FIBROSIS HCV CIRRHOSIS HBV CIRRHOSIS LIVER KUPPER CELLS TAMs SNP
researchProduct